15.24
price down icon1.99%   -0.31
 
loading
Schlusskurs vom Vortag:
$15.55
Offen:
$15.48
24-Stunden-Volumen:
60,700
Relative Volume:
0.52
Marktkapitalisierung:
$315.57M
Einnahmen:
$306.91M
Nettoeinkommen (Verlust:
$-59.11M
KGV:
-101.60
EPS:
-0.15
Netto-Cashflow:
$6.35M
1W Leistung:
-3.42%
1M Leistung:
+21.53%
6M Leistung:
+39.36%
1J Leistung:
-3.45%
1-Tages-Spanne:
Value
$15.11
$15.59
1-Wochen-Bereich:
Value
$15.11
$16.21
52-Wochen-Spanne:
Value
$7.08
$17.49

Amarin Corp Adr Stock (AMRN) Company Profile

Name
Firmenname
Amarin Corp Adr
Name
Telefon
353 1 6699 020
Name
Adresse
SPACES SOUTH DOCKLANDS, BLOCK C, DUBLIN 2
Name
Mitarbeiter
275
Name
Twitter
@amarincorp
Name
Nächster Verdiensttermin
2025-03-12
Name
Neueste SEC-Einreichungen
Name
AMRN's Discussions on Twitter

Vergleichen Sie AMRN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
AMRN
Amarin Corp Adr
15.24 326.76M 306.91M -59.11M 6.35M -0.15
Drug Manufacturers - General icon
LLY
Lilly Eli Co
776.44 692.83B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
167.93 373.35B 90.63B 22.66B 18.57B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
187.11 329.24B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
116.83 231.66B 55.19B 13.65B 16.81B 6.86
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
66.78 298.68B 43.59B 15.04B 10.74B 3.3766

Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-11-20 Fortgesetzt JP Morgan Underweight
2023-10-25 Herabstufung Jefferies Buy → Hold
2023-01-06 Hochstufung Jefferies Hold → Buy
2022-05-06 Herabstufung JP Morgan Neutral → Underweight
2022-05-05 Herabstufung H.C. Wainwright Buy → Neutral
2022-05-05 Herabstufung SVB Leerink Outperform → Mkt Perform
2022-05-04 Herabstufung Northland Capital Outperform → Market Perform
2021-05-12 Herabstufung Goldman Neutral → Sell
2020-09-29 Fortgesetzt JP Morgan Neutral
2020-08-26 Eingeleitet Piper Sandler Overweight
2020-05-05 Eingeleitet Northland Capital Outperform
2020-03-31 Herabstufung Goldman Buy → Neutral
2020-03-31 Herabstufung Jefferies Buy → Hold
2020-03-31 Hochstufung Oppenheimer Underperform → Perform
2020-03-13 Hochstufung Goldman Neutral → Buy
2020-03-02 Eingeleitet Cowen Outperform
2020-02-18 Hochstufung Citigroup Neutral → Buy
2020-01-06 Eingeleitet JP Morgan Neutral
2019-12-16 Herabstufung Stifel Buy → Hold
2019-11-20 Eingeleitet Oppenheimer Underperform
2019-11-18 Herabstufung Citigroup Buy → Neutral
2019-11-15 Bestätigt SVB Leerink Outperform
2019-10-31 Eingeleitet Aegis Capital Buy
2019-10-15 Eingeleitet Goldman Neutral
2019-08-14 Eingeleitet SVB Leerink Outperform
2019-07-09 Bestätigt Jefferies Buy
2019-06-17 Eingeleitet ROTH Capital Buy
2019-03-22 Eingeleitet Stifel Buy
Alle ansehen

Amarin Corp Adr Aktie (AMRN) Neueste Nachrichten

pulisher
Jul 18, 2025

Zacks.com featured highlights include Mama's Creations, Bassett Furniture Industries and Amarin - Barchart.com

Jul 18, 2025
pulisher
Jul 10, 2025

KRYS Begins Dosing With Gene Therapy In Rare Eye Disease, Stock Up - Barchart.com

Jul 10, 2025
pulisher
Jul 10, 2025

RYTM Stock Rises On Upbeat Acquired Hypothalamic Obesity Study Data - Barchart.com

Jul 10, 2025
pulisher
Jul 09, 2025

PROK Surges More Than 500% On Upbeat Data From Kidney Cell Therapy Study - Barchart.com

Jul 09, 2025
pulisher
Jun 25, 2025

Amarin stock rises as Goldman Sachs raises price target on EU deal - Investing.com

Jun 25, 2025
pulisher
Jun 24, 2025

Amarin stock jumps after $25 million licensing deal with Recordati - Investing.com

Jun 24, 2025
pulisher
Jun 16, 2025

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jun 16, 2025
pulisher
Jun 06, 2025

KURA Stock Rises More Than 15% This Past Week: Here's Why - Barchart.com

Jun 06, 2025
pulisher
May 29, 2025

Is GSK PLC Sponsored ADR (GSK) Outperforming Other Medical Stocks This Year? - Yahoo Finance

May 29, 2025
pulisher
May 28, 2025

RCKT Stock Tanks On Patient Death In Danon Disease Study - Barchart.com

May 28, 2025
pulisher
May 28, 2025

TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate - Zacks Investment Research

May 28, 2025
pulisher
May 26, 2025

SpringWorks Gets CHMP Nod For Mirdametinib In Rare Disease - Barchart.com

May 26, 2025
pulisher
May 08, 2025

Amarin's Q1 Earnings Beat Estimates, Revenues Decline Y/Y - Barchart.com

May 08, 2025
pulisher
May 07, 2025

Amarin earnings beat by $0.04, revenue topped estimates - Investing.com

May 07, 2025
pulisher
Apr 28, 2025

Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025 - Barchart.com

Apr 28, 2025
pulisher
Apr 24, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 24, 2025
pulisher
Apr 18, 2025

Looking For A Top Momentum Stock? Check Out Amarin Corp ADR (NASDAQ: AMRN) - Stocksregister

Apr 18, 2025
pulisher
Apr 09, 2025

Amarin Takes Critical Step to Avoid Nasdaq Delisting with 1-for-20 Share Consolidation - Stock Titan

Apr 09, 2025
pulisher
Apr 09, 2025

Amarin announces ADS ratio change to meet Nasdaq requirements - Investing.com

Apr 09, 2025
pulisher
Apr 07, 2025

Major Shake-up: Investment Firm Leader Joins Amarin Board to Drive Shareholder Value - Stock Titan

Apr 07, 2025
pulisher
Apr 07, 2025

Amarin adds investment expert Michael Torok to Board By Investing.com - Investing.com

Apr 07, 2025
pulisher
Apr 07, 2025

Upcoming Stock Splits This Week (April 7 to April 11) – Stay Invested - markets.businessinsider.com

Apr 07, 2025
pulisher
Apr 02, 2025

A Look at New Gold Inc (NGD) Shares in the Recent Past Indicates Growth - Sete News

Apr 02, 2025
pulisher
Mar 31, 2025

Breakthrough: EPA Treatment Shows Double Impact on Heart Disease When Combined with Popular Diabetes Drug - Stock Titan

Mar 31, 2025
pulisher
Mar 28, 2025

Amarin announces board member departure ahead of annual meeting - Investing.com

Mar 28, 2025
pulisher
Mar 24, 2025

European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - TradingView

Mar 24, 2025
pulisher
Mar 19, 2025

European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading - TradingView

Mar 19, 2025
pulisher
Mar 19, 2025

Amarin urged to review strategy by major shareholders - Investing.com

Mar 19, 2025
pulisher
Mar 18, 2025

Assessing the Risk and Potential of Sempra’s (SRE) Stock - The News Heater

Mar 18, 2025
pulisher
Mar 13, 2025

Amarin Corporation plc (NASDAQ:AMRN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 13, 2025
pulisher
Mar 13, 2025

Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ... - Yahoo Finance

Mar 13, 2025
pulisher
Mar 12, 2025

Amarin Plc (AMRN) Q4 2024 Earnings Call Transcript - The Motley Fool

Mar 12, 2025
pulisher
Mar 12, 2025

Amarin announce splan to initiate ratio change under ADR program - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program - The Manila Times

Mar 12, 2025
pulisher
Mar 12, 2025

Amarin Corp. (AMRN) Announces 1-For-20 ADS Ratio Change to Maintain Nasdaq Listing - StreetInsider.com

Mar 12, 2025
pulisher
Mar 12, 2025

Amarin Plans Major ADR Restructuring: What This 1:20 Ratio Change Means for Investors - StockTitan

Mar 12, 2025
pulisher
Mar 12, 2025

Amarin Announces 1-for-20 Reverse Stock Split - TipRanks

Mar 12, 2025
pulisher
Feb 25, 2025

How Amarin's Latest European Reimbursement Victory Strengthens Its Cardiovascular Market Position - Stock Titan

Feb 25, 2025
pulisher
Feb 19, 2025

Will Amarin's Q4 Earnings Mark a Turning Point? Key Date and Details Revealed - Stock Titan

Feb 19, 2025
pulisher
Feb 13, 2025

Amarin Corp ADR (AMRN) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News

Feb 13, 2025
pulisher
Feb 12, 2025

European Equities Traded in the US as American Depositary Receipts Tread Water in Wednesday Trading - TradingView

Feb 12, 2025
pulisher
Feb 10, 2025

Amarin Corp ADR [AMRN] Stock bought by Insider Berg Aaron for $0.1 million - Knox Daily

Feb 10, 2025
pulisher
Feb 10, 2025

Ratios Uncovered: Breaking Down Amarin Corp ADR (AMRN)’s Trailing Twelve Months Metrics - The Dwinnex

Feb 10, 2025
pulisher
Feb 10, 2025

Checking in on Indivior Plc (INDV) after recent insiders movement - Knox Daily

Feb 10, 2025
pulisher
Feb 10, 2025

Ratios Uncovered: Breaking Down Neuronetics Inc (STIM)’s Trailing Twelve Months Metrics - The Dwinnex

Feb 10, 2025
pulisher
Feb 06, 2025

Are Smart Investors Making the Right Decision? Amarin Corp ADR (AMRN) - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Views of Wall Street’s Leading Experts on SciSparc Ltd - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Stocks of Talen Energy Corp (TLN) are poised to climb above their peers - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

Scholar Rock Holding Corp (SRRK) requires closer examination - US Post News

Feb 05, 2025
pulisher
Feb 05, 2025

Amarin Corp ADR (AMRN) shows promising results - US Post News

Feb 05, 2025
pulisher
Feb 04, 2025

Analysts review Amarin Corp ADR’s rating - Knox Daily

Feb 04, 2025

Finanzdaten der Amarin Corp Adr-Aktie (AMRN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_general SNY
$48.75
price up icon 1.71%
$110.17
price up icon 1.75%
drug_manufacturers_general PFE
$25.14
price up icon 3.63%
$305.69
price up icon 3.32%
drug_manufacturers_general MRK
$81.61
price up icon 2.90%
drug_manufacturers_general NVO
$66.78
price up icon 2.87%
Kapitalisierung:     |  Volumen (24h):